Literature DB >> 26699264

Genetic predisposition to acute lymphoblastic leukemia: Overview on behalf of the I-BFM ALL Host Genetic Variation Working Group.

Christian Peter Kratz1, Martin Stanulla2, Hélène Cavé3.   

Abstract

Environmental causes of childhood acute lymphoblastic leukemia (ALL) remain largely undiscovered. In contrast, multiple germline ALL risk variants have been identified in the recent years. Apart from the low-risk common ALL risk alleles identified through genome wide association studies, rare germline mutations that cause cancer prone syndromes have been found to be associated with an increased risk of developing ALL. Here, we review the germline genetic changes known to be associated with ALL.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Acute lymphoblastic leukemia; Cancer predisposition; Germline mutation; Risk variants

Mesh:

Year:  2015        PMID: 26699264     DOI: 10.1016/j.ejmg.2015.10.003

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  9 in total

1.  B-cell acute lymphoblastic leukemia with high mutation burden presenting in a child with constitutional mismatch repair deficiency.

Authors:  Benjamin Oshrine; Nanette Grana; Colin Moore; Johnny Nguyen; Melissa Crenshaw; Melissa Edwards; Sumedha Sudhaman; Victoria J Forster; Uri Tabori
Journal:  Blood Adv       Date:  2019-06-25

Review 2.  Genetic defects in hematopoietic transcription factors and predisposition to acute lymphoblastic leukemia.

Authors:  Yoshihiro Gocho; Jun J Yang
Journal:  Blood       Date:  2019-07-16       Impact factor: 22.113

3.  Predisposition to childhood acute lymphoblastic leukemia caused by a constitutional translocation disrupting ETV6.

Authors:  Tekla Järviaho; Benedicte Bang; Vasilios Zachariadis; Fulya Taylan; Jukka Moilanen; Merja Möttönen; C I Edvard Smith; Arja Harila-Saari; Riitta Niinimäki; Ann Nordgren
Journal:  Blood Adv       Date:  2019-09-24

Review 4.  Predispositions to Leukemia in Down Syndrome and Other Hereditary Disorders.

Authors:  Satoshi Saida
Journal:  Curr Treat Options Oncol       Date:  2017-07

Review 5.  Infectious triggers and novel therapeutic opportunities in childhood B cell leukaemia.

Authors:  Cesar Cobaleda; Carolina Vicente-Dueñas; Isidro Sanchez-Garcia
Journal:  Nat Rev Immunol       Date:  2021-02-08       Impact factor: 53.106

Review 6.  Primary Immunodeficiency and Cancer Predisposition Revisited: Embedding Two Closely Related Concepts Into an Integrative Conceptual Framework.

Authors:  Oskar A Haas
Journal:  Front Immunol       Date:  2019-02-12       Impact factor: 7.561

7.  Body mass index associated with childhood and adolescent high-risk B-cell acute lymphoblastic leukemia risk: A Children's Oncology Group report.

Authors:  Taumoha Ghosh; Michaela Richardson; Peter M Gordon; Justin R Ryder; Logan G Spector; Lucie M Turcotte
Journal:  Cancer Med       Date:  2020-07-24       Impact factor: 4.452

8.  Recurrent somatic mutations and low germline predisposition mutations in Korean ALL patients.

Authors:  Sang-Yong Shin; Hyeonah Lee; Seung-Tae Lee; Jong Rak Choi; Chul Won Jung; Hong Hoe Koo; Sun-Hee Kim
Journal:  Sci Rep       Date:  2021-04-26       Impact factor: 4.379

9.  Clinical efficacy and safety of 6-thioguanine in the treatment of childhood acute lymphoblastic leukemia: A protocol for systematic review and meta-analysis.

Authors:  Liang Chen; Huai-Xiu Yan; Xiao-Wei Liu; Wen-Xin Chen
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.